Misconduct Plan Due?

HEDGESVILLE, W.VA.—Guidelines for coping with scientific fraud and misconduct may be drafted by a joint committee of the American Association for the Advancement of Science and the American Bar Association. Draft guidelines could be prepared and discussed at the group’s next meeting in the spring of 1988, according to Albert H. Teich of the AAAS. Teich is project director of the subcommittee on scientific fraud and misconduct of the AAAS/ABA National Conference of Lawyers and Sc

Written byTabitha Powledge
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HEDGESVILLE, W.VA.—Guidelines for coping with scientific fraud and misconduct may be drafted by a joint committee of the American Association for the Advancement of Science and the American Bar Association.

Draft guidelines could be prepared and discussed at the group’s next meeting in the spring of 1988, according to Albert H. Teich of the AAAS. Teich is project director of the subcommittee on scientific fraud and misconduct of the AAAS/ABA National Conference of Lawyers and Scientists, which sponsored last month’s meeting here. The meeting ranged widely over such topics as types and frequency of misconduct, the role of lawyers in the investigations, and the behavior of academic institutions, funding agencies, professional societies and journals.

The value of such guidelines was underscored by the “war stories” presented at the meeting by leading actors in several recent cases. Their stories confirmed the fears of those who say that such accusations often lead ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies